Could Some Rheumatoid Arthritis Meds Help Lower Alzheimer's Risk?
Title: Could Some Rheumatoid Arthritis Meds Help Lower Alzheimer ' s Risk?Category: Health NewsCreated: 4/12/2022 12:00:00 AMLast Editorial Review: 4/12/2022 12:00:00 AM (Source: MedicineNet Alzheimer)
Source: MedicineNet Alzheimer - April 12, 2022 Category: Geriatrics Source Type: news

DMARD Prescribing Low for Older Adults With Rheumatoid Arthritis
MONDAY, April 11, 2022 -- Older adults with rheumatoid arthritis (RA) are undermedicated with disease-modifying antirheumatic drugs (DMARDs), according to a study published in the April issue of ACR Open Rheumatology. Jiha Lee, M.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 11, 2022 Category: Pharmaceuticals Source Type: news

Is Alzheimer's Risk Lower With TNF Inhibitors?
(MedPage Today) -- Tumor necrosis factor (TNF) inhibitors for rheumatoid arthritis were linked with a lower risk of Alzheimer's disease and related dementia, but only in people with cardiovascular disease, data from the DREAM (Drug Repurposing... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - April 8, 2022 Category: Psychiatry Source Type: news

U.S. FDA grants priority review to Roche ’s Actemra/RoActemra for the treatment of COVID-19 in hospitalised adults
If approved,Actemra/RoActemra would be the first U.S. FDA-approvedimmunomodulator for the treatment of COVID-19 inhospitalised patientsSince the beginning of the pandemic, more than one million peoplehospitalised with COVID-19 have been treated withActemra/RoActemra worldwide1Actemra/RoActemra is approved for the treatment of COVID-19 in many territories including the European UnionRoche has established a comprehensive access approach to improve availability ofActemra/RoActemra around the worldBasel, 04 April 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has acce...
Source: Roche Investor Update - April 4, 2022 Category: Pharmaceuticals Source Type: news

U.S. FDA grants priority review to Roche ’s Actemra/RoActemra for the treatment of COVID-19 in hospitalised adults
If approved,Actemra/RoActemra would be the first U.S. FDA-approvedimmunomodulator for the treatment of COVID-19 inhospitalised patientsSince the beginning of the pandemic, more than one million peoplehospitalised with COVID-19 have been treated withActemra/RoActemra worldwide1Actemra/RoActemra is approved for the treatment of COVID-19 in many territories including the European UnionRoche has established a comprehensive access approach to improve availability ofActemra/RoActemra around the worldBasel, 04 April 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has acce...
Source: Roche Media News - April 4, 2022 Category: Pharmaceuticals Source Type: news

Arthritis: Women more likely than men to develop rheumatoid arthritis - other risk factors
ARTHRITIS is a common autoimmune condition where the immune system attacks healthy tissue. Rheumatoid arthritis is less common than osteoarthritis, but it is nevertheless an important condition to be aware of. (Source: Daily Express - Health)
Source: Daily Express - Health - April 2, 2022 Category: Consumer Health News Source Type: news

Roche donates additional medicines and diagnostics for Ukraine
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the donation of additional medicines and diagnostics to Ukraine. Beyond the already communicated 150,000 packs of an antibiotic medicine the new donation includes another 4,600 packs of specialized medicines for the treatment of influenza, rheumatoid arthritis, SMA and various cancers. (Source: World Pharma News)
Source: World Pharma News - March 30, 2022 Category: Pharmaceuticals Tags: Featured Roche Business and Industry Source Type: news

Evaluation of peripheral neuropathy in lower limbs of patients with rheumatoid arthritis and its relation to fall risk - de Ara újo Pereira F, de Almeida Lourenço M, de Assis MR.
BACKGROUND: Rheumatoid Arthritis (RA) is a chronic disabling systemic disease characterized by joint inflammation, and extra-articular manifestations, including peripheral neuropathy, a condition that can be associated with changes in muscle strength, prop... (Source: SafetyLit)
Source: SafetyLit - March 25, 2022 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Some Heart Risks Stay Elevated in RA Patients Despite Biologic Tx
(MedPage Today) -- Hopes that biologic drugs for rheumatoid arthritis (RA) would cancel the extra cardiovascular risks normally seen with the disease dimmed a little in the face of findings from a population-based study from Scandinavia. Over... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - March 24, 2022 Category: Rheumatology Source Type: news

Common COVID Drug, Tocilizumab (Actemra), Might Be Useful at Lower Dose
THURSDAY, March 24, 2022 -- A lower dose of a widely used COVID-19 drug is just as effective as a higher dose, new research shows. Tocilizumab (Actemra) is a rheumatoid arthritis drug that has become the standard of care for treating severe... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 24, 2022 Category: General Medicine Source Type: news

Can Rheumatoid Arthritis Affect Your Ability to Walk? 9 Limitations
Title: Can Rheumatoid Arthritis Affect Your Ability to Walk? 9 LimitationsCategory: Diseases and ConditionsCreated: 3/24/2022 12:00:00 AMLast Editorial Review: 3/24/2022 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - March 24, 2022 Category: Rheumatology Source Type: news

Roche donates additional medicines and diagnostics for Ukraine
Basel, 23 March 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the donation of additional medicines and diagnostics to Ukraine.Beyond the already communicated 150,000 packs of an antibiotic medicine the new donation includes another 4,600 packs of specialized medicines for the treatment of influenza, rheumatoid arthritis, SMA and various cancers. We are also donating reagents and consumables for automatic testing of up to 120,000 blood donations and 31,000 units for diabetes management.This latest donation demonstrates our commitment to meeting the need for Roche medicines and diagnostics in Ukraine whenever pos...
Source: Roche Media News - March 23, 2022 Category: Pharmaceuticals Source Type: news

Roche donates additional medicines and diagnostics for Ukraine
Basel, 23 March 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the donation of additional medicines and diagnostics to Ukraine.Beyond the already communicated 150,000 packs of an antibiotic medicine the new donation includes another 4,600 packs of specialized medicines for the treatment of influenza, rheumatoid arthritis, SMA and various cancers. We are also donating reagents and consumables for automatic testing of up to 120,000 blood donations and 31,000 units for diabetes management.This latest donation demonstrates our commitment to meeting the need for Roche medicines and diagnostics in Ukraine whenever pos...
Source: Roche Investor Update - March 23, 2022 Category: Pharmaceuticals Source Type: news

Is Rheumatoid Arthritis Caused by Sugar?
Title: Is Rheumatoid Arthritis Caused by Sugar?Category: Diseases and ConditionsCreated: 3/23/2022 12:00:00 AMLast Editorial Review: 3/23/2022 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - March 23, 2022 Category: Rheumatology Source Type: news

Difference Rheumatoid Arthritis vs. Fibromyalgia
What Is the Difference Between Rheumatoid Arthritis vs. Fibromyalgia? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - March 23, 2022 Category: General Medicine Source Type: news